Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs

Journal of the Autonomic Nervous System

Volumn 73, Issue 2-3, 1998, Pages 80-85

  Mahns, David A ^a   Lacroix, J Silvain ^a   Potter, Erica K ^a  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

NPY; Parasympathetic vasodilatation; Y2

Indexed keywords

ATROPINE; CAPSAICIN; NEUROPEPTIDE Y RECEPTOR AGONIST;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANTICHOLINERGIC EFFECT; ARTICLE; BLOOD FLOW; BRONCHIAL ARTERY; DOG; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; VAGUS NERVE STIMULATION; VASODILATATION;

ANESTHESIA; ANIMALS; ATROPINE; BRONCHI; BRONCHODILATOR AGENTS; CAPSAICIN; CHOLINERGIC FIBERS; DOGS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; FEMALE; MALE; NEURAL INHIBITION; NEURONS, AFFERENT; NEUROPEPTIDE Y; PARASYMPATHETIC NERVOUS SYSTEM; PEPTIDE FRAGMENTS; PULMONARY CIRCULATION; RECEPTORS, NEUROPEPTIDE Y; SYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE; VASODILATION;

EID: 0031766770     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(98)00086-1     Document Type: Article

References (30)

1. Coleridge H.M., Coleridge J.C., Green J.F., Parsons G.H. Pulmonary C-fiber stimulation by capsaicin evokes reflex cholinergic bronchial vasodilation in sheep. J. Appl. Physiol. 72:1992;770-778.
2. Dey R.D., Shannon W.A. Jr., Said S.I. Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat and human subjects. Cell and Tissue Research. 220:1981;231-238.
3. Gardner T.D., Potter E.K. Dependence of non-adrenergic inhibition of cardiac vagal action on peak frequency of sympathetic stimulation in the dog. J. Physiol. 405:1988;115-122.
4. Glover W.E. Increased sensitivity of rabbit ear artery to noradrenaline following perivascular nerve stimulation may be a response to neuropeptide Y released as cotransmitter. Clin. Exp. Pharmacol. Physiol. 12:1985;227-230.
5. Gustafsson L. Influence of adenosine on responses to vagal nerve stimulation in the anesthetized rabbit. Acta Physiol. Scand. 111:1981;263-268.
6. Keith I.M., Pelto-Huikko M., Schalling M., Hokfelt T. Calcitonin gene-related peptide and its mRNA in pulmonary neuroendocrine cells and ganglia. Histochemistry. 96:1991;311-315.
7. 2 prejunctional receptor. Br. J. Pharmacol. 113:1994;479-484.
8. Lacroix J.S., Ulman L.G., Potter E.K. Sympathetic and parasympathetic interaction in vascular control of the nasal mucosa in anaesthetized cats. J. Physiol. 480:1994;325-331.
9. Lundberg J.M., Tatemoto K. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol. Scand. 116:1982;393-402.
10. Lundberg J.M., Terenius L.U., Martling C.R., Tatemoto K., Mutt V., Polak J., Bloom S., Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol. Scand. 116:1982;477-480.
11. Lundberg J.M., Rudehill A., Sollevi A., Fried G., Wallin G. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience. 28:1989;475-486.
12. Maggi C.A. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Progress in Neurobiology. 45:1995;1-98.
13. Martling C.R., Matran R., Alving K., Lacroix J.S., Lundberg J.M. Vagal vasodilatory mechanisms in the pig bronchial circulation preferentially involves sensory nerves. Neurosci. Lett. 96:1989;306-311.
14. Martling C.R., Matran R., Alving K., Hokfelt T., Lundberg J.M. Innervation of lower airways and neuropeptide effects on bronchial and vascular tone in the pig. Cell and Tissue Research. 260:1990;223-233.
15. Matran R., Alving K., Martling C.R., Lacroix J.S., Lundberg J.M. Vagally mediated vasodilatation by motor and sensory nerves in the tracheal and bronchial circulation of the pig. Acta Physiol. Scand. 135:1989;29-37.
16. McCormack D.G., Salonen R.O., Barnes P.J. Effect of sensory neuropeptides on canine bronchial and pulmonary vessels in vitro. Life Sciences. 45:1989;2405-2412.
17. Pernow J., Lundberg J.M., Kaijser L., Hjemdahl P., Theodorsson-Norheim E., Martinsson A., Pernow B. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathethic activation in man. Clinical Physiology. 6:1986;561-578.
18. Pernow J., Lundberg J.M., Kaijser L. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans. J. Cardiovasc. Pharmacol. 12:1988;593-599.
19. Pisarri T.E., Coleridge H.M., Coleridge J.C. Reflex bronchial vasodilation in dogs evoked by injection of a small volume of water into a bronchus. J. Appl. Physiol. 75:1993;2195-2202.
20. Pisarri T.E., Coleridge J.C., Coleridge H.M. Capsaicin-induced bronchial vasodilation in dogs: central and peripheral neural mechanisms. J. Appl. Physiol. 74:1993;259-266.
21. Potter E.K. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y? Neurosci. Lett. 54:1985;117-121.
22. Potter E.K. Guanethidine blocks neuropeptide Y-like inhibitory action of sympathetic nerves on cardiac vagus. J. Auton. Nerv. Syst. 21:1987;87-90.
23. Potter E.K. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y. Neurosci. Lett. 83:1987;101-106.
24. Potter E.K., Mitchell L., McCloskey M.J., Tseng A., Goodman A.E., Shine J., McCloskey D.I. Pre- and postjunctional actions of neuropeptide Y and related peptides. Regulatory Peptides. 25:1989;167-177.
25. 2) receptor. Eur. J. Pharmacol. 267:1994;253-262.
26. Ulman L.G., Potter E.K., McCloskey D.I., Morris M.J. Post-exercise depression of baroreflex slowing of the heart in humans. Clinical Physiology. 17:1997;299-309.
27. Wahlestedt C., Hakanson R. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and postjunctional receptors be distinguished? Medical Biology. 64:1986;85-88.
28. Wahlestedt C., Yanaihara N., Hakanson R. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regulatory Peptides. 13:1986;307-318.
29. Warner M.R., Levy M.N. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Circ. Res. 65:1989;1536-1546.
30. Zar, J.H., Biostatistical Analysis, 2nd edn., Prentice-Hall, London, 1984.